[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-001", "question": "A 45-year-old male presents with syncope. ECG shows sinus rhythm with first-degree AV block and a right bundle branch block. Echocardiogram reveals a left ventricular ejection fraction (LVEF) of 42% with mild LV dilation. Genetic testing confirms a pathogenic variant in the LMNA gene (Lamin A/C). He has no history of sustained ventricular tachycardia. Which of the following is the most appropriate management?", "options": ["Implantation of a dual-chamber pacemaker", "Implantation of an implantable cardioverter-defibrillator (ICD)", "Implantation of an implantable loop recorder", "Initiation of Amiodarone", "Initiation of Metoprolol and reassessment of LVEF in 3 months"], "answer": "B", "answer_index": 1, "explanation": "Lamin A/C (LMNA) cardiomyopathy carries a disproportionately high risk of malignant ventricular arrhythmias and sudden cardiac death, often independent of the degree of LV dysfunction. Current guidelines recommend ICD implantation for patients with an LMNA mutation and risk factors such as AV block, male sex, or non-missense mutations, even if the LVEF is >35%. A pacemaker alone addresses the conduction disease but leaves the patient unprotected against the high risk of fatal ventricular arrhythmias.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 45-year-old male with syncope, LMNA cardiomyopathy (confirmed pathogenic variant), LVEF 42%, first-degree AV block, and RBBB. The key discriminating findings are: (1) confirmed LMNA mutation, (2) syncope, (3) conduction disease (AV block + RBBB), (4) male sex, and (5) LVEF 42%. LMNA cardiomyopathy carries exceptionally high arrhythmic risk independent of LVEF, with sudden cardiac death often occurring even with preserved systolic function. Current guidelines (HRS/ACC/AHA) recommend ICD for LMNA patients with risk factors including non-sustained VT, conduction disease, male sex, or non-missense mutations, regardless of LVEF >35%. This patient has multiple high-risk features (syncope, conduction disease, male). Option B (ICD) is the established standard. Option A (pacemaker alone) addresses bradycardia but ignores lethal arrhythmia risk. Option E (beta-blocker + reassess) delays definitive protection. Options C and D are inappropriate for primary prevention in this high-risk scenario. The item is logically valid with a single defensible best answer matching the key. Medical accuracy is excellent, reflecting current specialized guidelines for LMNA cardiomyopathy. No fix needed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 45-year-old male with syncope, LMNA cardiomyopathy (confirmed pathogenic variant), LVEF 42%, first-degree AV block, and RBBB. The key discriminating findings are: (1) confirmed LMNA mutation, (2) syncope, (3) conduction disease (AV block + RBBB), (4) male sex, and (5) LVEF 42%. LMNA cardiomyopathy carries exceptionally high arrhythmic risk independent of LVEF, with sudden cardiac death often occurring even with preserved systolic function. Current guidelines (HRS/ACC/AHA) recommend ICD for LMNA patients with risk factors including non-sustained VT, conduction disease, male sex, or non-missense mutations, regardless of LVEF >35%. This patient has multiple high-risk features (syncope, conduction disease, male). Option B (ICD) is the established standard. Option A (pacemaker alone) addresses bradycardia but ignores lethal arrhythmia risk. Option E (beta-blocker + reassess) delays definitive protection. Options C and D are inappropriate for primary prevention in this high-risk scenario. The item is logically valid with a single defensible best answer matching the key. Medical accuracy is excellent, reflecting current specialized guidelines for LMNA cardiomyopathy. No fix needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-002", "question": "A 68-year-old male presents with a 3-week history of brief, involuntary jerking movements of his right face and arm, occurring up to 40 times per day. He remains conscious during these events. Interictal EEG and brain MRI are unremarkable. He is beginning to show signs of short-term memory impairment. Which of the following is the most appropriate initial treatment?", "options": ["Levetiracetam", "Carbamazepine", "Intravenous Methylprednisolone", "Tissue Plasminogen Activator (tPA)", "Haloperidol"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation is classic for faciobrachial dystonic seizures (FBDS), which are pathognomonic for Anti-LGI1 encephalitis (a form of limbic encephalitis). These seizures are characteristically resistant to standard anti-epileptic drugs but respond dramatically to immunotherapy (steroids, IVIG). Early recognition and treatment with immunotherapy are crucial to prevent the progression to severe cognitive impairment and full-blown limbic encephalitis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 68-year-old male with brief, frequent (up to 40/day), stereotyped involuntary jerking movements of right face and arm with preserved consciousness, unremarkable interictal EEG/MRI, and emerging short-term memory impairment. These key discriminating findings—high-frequency focal motor events, normal structural/electrical studies, and cognitive decline—strongly suggest faciobrachial dystonic seizures (FBDS), pathognomonic for anti-LGI1 encephalitis. FBDS are notoriously refractory to conventional antiepileptic drugs (making levetiracetam and carbamazepine suboptimal) but respond dramatically to early immunotherapy. Intravenous methylprednisolone (C) is the appropriate initial treatment to prevent progression to severe limbic encephalitis. tPA (D) is for acute ischemic stroke, not applicable here. Haloperidol (E) treats movement disorders of different etiology. The keyed answer C is medically accurate and uniquely defensible based on the clinical syndrome described. No logical contradictions exist; the stem provides sufficient detail to identify FBDS and select immunotherapy as first-line. Medical accuracy is high (score 5): recognition and early immunotherapy for anti-LGI1 encephalitis align with current neurological consensus. Minimal fix: none needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 68-year-old male with brief, frequent (up to 40/day), stereotyped involuntary jerking movements of right face and arm with preserved consciousness, unremarkable interictal EEG/MRI, and emerging short-term memory impairment. These key discriminating findings—high-frequency focal motor events, normal structural/electrical studies, and cognitive decline—strongly suggest faciobrachial dystonic seizures (FBDS), pathognomonic for anti-LGI1 encephalitis. FBDS are notoriously refractory to conventional antiepileptic drugs (making levetiracetam and carbamazepine suboptimal) but respond dramatically to early immunotherapy. Intravenous methylprednisolone (C) is the appropriate initial treatment to prevent progression to severe limbic encephalitis. tPA (D) is for acute ischemic stroke, not applicable here. Haloperidol (E) treats movement disorders of different etiology. The keyed answer C is medically accurate and uniquely defensible based on the clinical syndrome described. No logical contradictions exist; the stem provides sufficient detail to identify FBDS and select immunotherapy as first-line. Medical accuracy is high (score 5): recognition and early immunotherapy for anti-LGI1 encephalitis align with current neurological consensus. Minimal fix: none needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-003", "question": "A 55-year-old female is admitted to the ICU with sepsis and severe malnutrition. She has a history of chronic back pain managed with acetaminophen. Arterial blood gas shows pH 7.26, pCO2 28 mmHg, HCO3 12 mEq/L. Serum chemistry shows Na 140, Cl 104, BUN 18, Cr 0.8. Lactate is 1.1 mmol/L. Serum ketones are negative. Measured serum osmolality is 295 mOsm/kg (calculated 290). Which of the following is the most likely etiology of her metabolic acidosis?", "options": ["Methanol intoxication", "D-lactic acidosis", "Pyroglutamic acidosis (5-oxoproline accumulation)", "Propylene glycol toxicity", "Salicylate toxicity"], "answer": "C", "answer_index": 2, "explanation": "The patient has a high anion gap metabolic acidosis (AG = 24) with a normal lactate, no ketones, normal renal function, and a normal osmol gap (ruling out toxic alcohols like methanol or propylene glycol). The combination of chronic acetaminophen use, sepsis, and malnutrition leads to glutathione depletion, causing a disruption in the gamma-glutamyl cycle and accumulation of 5-oxoproline (pyroglutamic acid). This is an under-recognized cause of high anion gap acidosis in this specific patient population.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 55-year-old female with sepsis, severe malnutrition, and chronic acetaminophen use presenting with high anion gap metabolic acidosis (AG = 140 - 104 - 12 = 24). Key discriminating findings: (1) elevated AG acidosis, (2) normal lactate (1.1), (3) negative ketones, (4) normal renal function (Cr 0.8), (5) normal osmol gap (295 - 290 = 5, <10), (6) chronic acetaminophen use, (7) malnutrition, (8) sepsis. The normal osmol gap excludes toxic alcohols (methanol, propylene glycol). Normal lactate argues against D-lactic acidosis. Absence of salicylate history and the specific triad of acetaminophen + malnutrition + critical illness strongly point to pyroglutamic acidosis. Acetaminophen depletes glutathione, especially in malnourished/septic patients, disrupting the gamma-glutamyl cycle and causing 5-oxoproline accumulation. Each alternative is appropriately excluded by stem findings: A/D ruled out by normal osmol gap, B by normal L-lactate, E by absence of salicylate exposure. The item is logically valid with a unique best answer matching the key. Medical accuracy is excellent, reflecting current understanding of this under-recognized entity. No fix needed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 55-year-old female with sepsis, severe malnutrition, and chronic acetaminophen use presenting with high anion gap metabolic acidosis (AG = 140 - 104 - 12 = 24). Key discriminating findings: (1) elevated AG acidosis, (2) normal lactate (1.1), (3) negative ketones, (4) normal renal function (Cr 0.8), (5) normal osmol gap (295 - 290 = 5, <10), (6) chronic acetaminophen use, (7) malnutrition, (8) sepsis. The normal osmol gap excludes toxic alcohols (methanol, propylene glycol). Normal lactate argues against D-lactic acidosis. Absence of salicylate history and the specific triad of acetaminophen + malnutrition + critical illness strongly point to pyroglutamic acidosis. Acetaminophen depletes glutathione, especially in malnourished/septic patients, disrupting the gamma-glutamyl cycle and causing 5-oxoproline accumulation. Each alternative is appropriately excluded by stem findings: A/D ruled out by normal osmol gap, B by normal L-lactate, E by absence of salicylate exposure. The item is logically valid with a unique best answer matching the key. Medical accuracy is excellent, reflecting current understanding of this under-recognized entity. No fix needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-004", "question": "A 34-year-old male presents with progressive dyspnea. He has a BMI of 17 kg/m2. Chest radiography shows apical pleural thickening. High-resolution CT demonstrates upper-lobe predominant subpleural fibrosis and a flattened chest configuration ('platythorax'). He has no history of asbestos exposure or connective tissue disease. Which of the following is the most likely diagnosis?", "options": ["Idiopathic Pulmonary Fibrosis (IPF)", "Pleuroparenchymal Fibroelastosis (PPFE)", "Chronic Hypersensitivity Pneumonitis", "Lymphangioleiomyomatosis (LAM)", "Pulmonary Alveolar Proteinosis"], "answer": "B", "answer_index": 1, "explanation": "Pleuroparenchymal Fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia characterized by fibrosis of the visceral pleura and subpleural lung parenchyma, predominantly in the upper lobes. The radiographic hallmark is the 'platythorax' (flattening of the chest cage) due to fibrosis progression. This contrasts with IPF (lower lobe predominant) and Hypersensitivity Pneumonitis (mosaic attenuation, centrilobular nodules).", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The vignette describes a young male with low BMI (17 kg/m²), progressive dyspnea, apical pleural thickening, upper-lobe predominant subpleural fibrosis, and platythorax on HRCT, with no asbestos or connective tissue disease history. These findings are pathognomonic for PPFE. Key discriminating features: (1) upper-lobe predominance with pleural involvement excludes IPF (lower-lobe, subpleural, basilar); (2) platythorax is highly specific for PPFE; (3) low BMI reflects the wasting often seen in PPFE; (4) young age and upper-lobe distribution argue against IPF. Option C (chronic HP) typically shows mosaic attenuation, centrilobular nodules, and mid-to-lower zone involvement. Option D (LAM) occurs almost exclusively in women of childbearing age with cystic changes, not fibrosis. Option E (PAP) shows ground-glass opacities with crazy-paving pattern, not fibrosis. The keyed answer (B) is the only option consistent with all stem features. No logical flaws: stem provides sufficient discriminating details, options are mutually exclusive, and the key matches the unique best answer. Medical accuracy: description aligns with current understanding of PPFE as a rare IIP with characteristic upper-lobe fibrosis and platythorax. Minimal fix: none needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The vignette describes a young male with low BMI (17 kg/m²), progressive dyspnea, apical pleural thickening, upper-lobe predominant subpleural fibrosis, and platythorax on HRCT, with no asbestos or connective tissue disease history. These findings are pathognomonic for PPFE. Key discriminating features: (1) upper-lobe predominance with pleural involvement excludes IPF (lower-lobe, subpleural, basilar); (2) platythorax is highly specific for PPFE; (3) low BMI reflects the wasting often seen in PPFE; (4) young age and upper-lobe distribution argue against IPF. Option C (chronic HP) typically shows mosaic attenuation, centrilobular nodules, and mid-to-lower zone involvement. Option D (LAM) occurs almost exclusively in women of childbearing age with cystic changes, not fibrosis. Option E (PAP) shows ground-glass opacities with crazy-paving pattern, not fibrosis. The keyed answer (B) is the only option consistent with all stem features. No logical flaws: stem provides sufficient discriminating details, options are mutually exclusive, and the key matches the unique best answer. Medical accuracy: description aligns with current understanding of PPFE as a rare IIP with characteristic upper-lobe fibrosis and platythorax. Minimal fix: none needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-005", "question": "A 24-year-old African American male presents with cyanosis and shortness of breath after taking dapsone for a skin lesion. Pulse oximetry reads 85% and does not improve with supplemental oxygen. Arterial blood gas shows a normal PaO2 but methemoglobin level is 18%. He has a known history of hemolysis after ingesting fava beans. Which of the following is the most appropriate treatment?", "options": ["Methylene Blue 1 mg/kg IV", "Ascorbic Acid (Vitamin C) IV", "Hydroxocobalamin IV", "Hyperbaric Oxygen Therapy", "Sodium Thiosulfate IV"], "answer": "B", "answer_index": 1, "explanation": "The patient has methemoglobinemia precipitated by dapsone. However, his history of hemolysis with fava beans strongly suggests Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Methylene blue is contraindicated in G6PD deficiency because it requires NADPH (generated by G6PD) to reduce methemoglobin; without G6PD, methylene blue is ineffective and can induce severe hemolysis. Ascorbic acid (Vitamin C) or exchange transfusion is the appropriate management.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem provides clear discriminating clues: (1) methemoglobinemia (18%, symptomatic with cyanosis unresponsive to O2) from dapsone, (2) history of hemolysis after fava beans indicating G6PD deficiency. The question tests recognition that methylene blue—the standard first-line treatment for methemoglobinemia—is absolutely contraindicated in G6PD deficiency because it requires NADPH generated by the G6PD pathway to reduce methemoglobin; in G6PD deficiency, methylene blue is ineffective and causes severe hemolysis. Ascorbic acid (B) is the appropriate alternative, though slower-acting. Option A is contraindicated. Option C (hydroxocobalamin) treats cyanide toxicity. Option D (hyperbaric oxygen) does not reduce methemoglobin. Option E (sodium thiosulfate) treats cyanide toxicity. The keyed answer B is defensible as the single best pharmacologic option given the G6PD deficiency. Medical accuracy: The item correctly identifies the contraindication and appropriate alternative. The methemoglobin level (18%) is symptomatic and warrants treatment. Minor point: exchange transfusion would be considered for severe cases (>30%) or refractory symptoms, but is not among the options. No logical flaws or medical inaccuracies present. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem provides clear discriminating clues: (1) methemoglobinemia (18%, symptomatic with cyanosis unresponsive to O2) from dapsone, (2) history of hemolysis after fava beans indicating G6PD deficiency. The question tests recognition that methylene blue—the standard first-line treatment for methemoglobinemia—is absolutely contraindicated in G6PD deficiency because it requires NADPH generated by the G6PD pathway to reduce methemoglobin; in G6PD deficiency, methylene blue is ineffective and causes severe hemolysis. Ascorbic acid (B) is the appropriate alternative, though slower-acting. Option A is contraindicated. Option C (hydroxocobalamin) treats cyanide toxicity. Option D (hyperbaric oxygen) does not reduce methemoglobin. Option E (sodium thiosulfate) treats cyanide toxicity. The keyed answer B is defensible as the single best pharmacologic option given the G6PD deficiency. Medical accuracy: The item correctly identifies the contraindication and appropriate alternative. The methemoglobin level (18%) is symptomatic and warrants treatment. Minor point: exchange transfusion would be considered for severe cases (>30%) or refractory symptoms, but is not among the options. No logical flaws or medical inaccuracies present. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-006", "question": "A 14-year-old boy with a history of exercise-induced syncope is diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) confirmed by an RyR2 mutation. He is compliant with high-dose Nadolol. A repeat exercise stress test shows a reduction in arrhythmia burden, but he still develops runs of bidirectional ventricular tachycardia at peak exertion. Which of the following is the best next step in management?", "options": ["Switch Nadolol to Metoprolol Succinate", "Add Flecainide", "Perform Radiofrequency Ablation of the ventricular focus", "Implant a dual-chamber pacemaker", "Add Verapamil"], "answer": "B", "answer_index": 1, "explanation": "In patients with CPVT who have breakthrough arrhythmias despite optimal beta-blocker therapy (preferably Nadolol or Propranolol), the addition of Flecainide is the guideline-recommended next step. Flecainide has a direct blocking effect on the cardiac ryanodine receptor (RyR2), addressing the underlying mechanism. Radiofrequency ablation is generally ineffective due to the polymorphic/multifocal nature of the arrhythmia.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 14-year-old with genetically confirmed CPVT (RyR2 mutation) on high-dose Nadolol who has persistent bidirectional VT at peak exertion despite reduced arrhythmia burden. Key discriminating findings: (1) confirmed CPVT with RyR2 mutation, (2) compliant with optimal beta-blocker (Nadolol), (3) breakthrough arrhythmias persist. The question asks for best next management step. Option B (Add Flecainide) is correct: current guidelines recommend adding Flecainide to beta-blockers for breakthrough arrhythmias in CPVT, as it directly blocks RyR2 calcium release. Option A (switch to Metoprolol) is inferior—Nadolol/Propranolol are preferred beta-blockers for CPVT due to longer half-life and lack of intrinsic sympathomimetic activity. Option C (ablation) is ineffective for polymorphic/multifocal CPVT arrhythmias. Option D (pacemaker alone) doesn't address arrhythmia mechanism. Option E (Verapamil) is contraindicated—calcium channel blockers can worsen CPVT. The item is medically accurate, reflects current CPVT management guidelines, and the stem provides sufficient detail to identify a unique best answer. No logical flaws or medical inaccuracies detected. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 14-year-old with genetically confirmed CPVT (RyR2 mutation) on high-dose Nadolol who has persistent bidirectional VT at peak exertion despite reduced arrhythmia burden. Key discriminating findings: (1) confirmed CPVT with RyR2 mutation, (2) compliant with optimal beta-blocker (Nadolol), (3) breakthrough arrhythmias persist. The question asks for best next management step. Option B (Add Flecainide) is correct: current guidelines recommend adding Flecainide to beta-blockers for breakthrough arrhythmias in CPVT, as it directly blocks RyR2 calcium release. Option A (switch to Metoprolol) is inferior—Nadolol/Propranolol are preferred beta-blockers for CPVT due to longer half-life and lack of intrinsic sympathomimetic activity. Option C (ablation) is ineffective for polymorphic/multifocal CPVT arrhythmias. Option D (pacemaker alone) doesn't address arrhythmia mechanism. Option E (Verapamil) is contraindicated—calcium channel blockers can worsen CPVT. The item is medically accurate, reflects current CPVT management guidelines, and the stem provides sufficient detail to identify a unique best answer. No logical flaws or medical inaccuracies detected. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-007", "question": "A 26-year-old female with a history of sensorineural hearing loss and short stature presents with acute onset aphasia and right-sided hemiparesis. MRI shows a T2-hyperintense lesion in the left temporal lobe that does not conform to a vascular territory. Serum lactate is elevated. Which of the following agents is indicated for the acute management of this condition?", "options": ["Intravenous Tissue Plasminogen Activator (tPA)", "Intravenous Arginine", "Intravenous Heparin", "High-dose Aspirin", "Plasma Exchange"], "answer": "B", "answer_index": 1, "explanation": "The clinical picture (stroke-like episode not respecting vascular territories, hearing loss, elevated lactate) is classic for MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). The stroke-like episodes are due to metabolic failure and microvascular angiopathy (nitric oxide deficiency), not thrombotic occlusion. Intravenous Arginine is the recommended acute treatment to improve nitric oxide availability and cerebral blood flow. tPA is not indicated and could be harmful.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a young woman with sensorineural hearing loss, short stature, acute aphasia/hemiparesis, non-vascular-territory T2-hyperintense lesion, and elevated lactate—a constellation highly specific for MELAS syndrome. The stroke-like episodes in MELAS result from metabolic crisis and nitric oxide deficiency, not thromboembolic occlusion. Key discriminators: (1) non-vascular distribution rules out typical ischemic stroke, (2) elevated lactate + hearing loss + short stature point to mitochondrial disease, (3) young age without typical stroke risk factors. Keyed answer (B, IV arginine) is correct: arginine acutely improves NO availability and cerebral perfusion in MELAS stroke-like episodes, supported by case series and expert consensus. Alternative assessment: (A) tPA contraindicated—not thromboembolic; (C) heparin inappropriate—no thrombosis; (D) aspirin ineffective for metabolic crisis; (E) plasma exchange lacks evidence in MELAS. Medical accuracy: The item correctly identifies arginine as acute MELAS management per current mitochondrial disease guidelines. No logical flaws; stem provides sufficient discriminating features for unique best answer. Minimal fix: None needed—item is valid and accurate as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a young woman with sensorineural hearing loss, short stature, acute aphasia/hemiparesis, non-vascular-territory T2-hyperintense lesion, and elevated lactate—a constellation highly specific for MELAS syndrome. The stroke-like episodes in MELAS result from metabolic crisis and nitric oxide deficiency, not thromboembolic occlusion. Key discriminators: (1) non-vascular distribution rules out typical ischemic stroke, (2) elevated lactate + hearing loss + short stature point to mitochondrial disease, (3) young age without typical stroke risk factors. Keyed answer (B, IV arginine) is correct: arginine acutely improves NO availability and cerebral perfusion in MELAS stroke-like episodes, supported by case series and expert consensus. Alternative assessment: (A) tPA contraindicated—not thromboembolic; (C) heparin inappropriate—no thrombosis; (D) aspirin ineffective for metabolic crisis; (E) plasma exchange lacks evidence in MELAS. Medical accuracy: The item correctly identifies arginine as acute MELAS management per current mitochondrial disease guidelines. No logical flaws; stem provides sufficient discriminating features for unique best answer. Minimal fix: None needed—item is valid and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-008", "question": "A 32-year-old female is evaluated for palpitations. Labs reveal a TSH of 7.2 mIU/L (High) and Free T4 of 2.9 ng/dL (High). An MRI of the pituitary shows a 5mm hypoenhancing lesion. Sex Hormone Binding Globulin (SHBG) levels are elevated. Which of the following is the most likely diagnosis?", "options": ["Resistance to Thyroid Hormone (RTH) beta", "TSH-secreting pituitary adenoma (TSHoma)", "Graves' disease", "Familial Dysalbuminemic Hyperthyroxinemia", "Heterophile antibody interference"], "answer": "B", "answer_index": 1, "explanation": "Both RTH and TSHoma present with inappropriate TSH secretion (high T4, non-suppressed TSH). The key differentiator is the peripheral tissue response. In TSHoma, peripheral tissues (like the liver) are sensitive to the high thyroid hormone levels, resulting in elevated markers of thyroid action such as Sex Hormone Binding Globulin (SHBG). In RTH, the peripheral tissues are resistant, so SHBG levels are typically normal. The pituitary lesion supports TSHoma, but incidentalomas are common; the metabolic profile (high SHBG) confirms the diagnosis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem presents a 32-year-old female with palpitations, elevated TSH (7.2 mIU/L) and elevated Free T4 (2.9 ng/dL)—a pattern of inappropriate TSH secretion. Key discriminating findings include: (1) elevated SHBG indicating peripheral thyroid hormone action, (2) 5mm pituitary lesion on MRI. The question asks for the most likely diagnosis among causes of elevated TSH with elevated T4. RTH-beta (A) would show normal/low SHBG due to peripheral resistance; the elevated SHBG excludes this. TSHoma (B) fits perfectly: inappropriate TSH secretion, peripheral tissue sensitivity (elevated SHBG), and pituitary adenoma. Graves' disease (C) would show suppressed TSH. Familial dysalbuminemic hyperthyroxinemia (D) would show normal TSH and normal free T4 by equilibrium dialysis. Heterophile antibody interference (E) causes laboratory artifact without true thyroid hormone excess or elevated SHBG. The keyed answer B is uniquely defensible based on the constellation of biochemical findings and imaging. Medical accuracy is excellent; the distinction between RTH and TSHoma via SHBG is a classic teaching point. No fix needed—this is a well-constructed item testing appropriate differential diagnosis of thyrotoxicosis with non-suppressed TSH.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem presents a 32-year-old female with palpitations, elevated TSH (7.2 mIU/L) and elevated Free T4 (2.9 ng/dL)—a pattern of inappropriate TSH secretion. Key discriminating findings include: (1) elevated SHBG indicating peripheral thyroid hormone action, (2) 5mm pituitary lesion on MRI. The question asks for the most likely diagnosis among causes of elevated TSH with elevated T4. RTH-beta (A) would show normal/low SHBG due to peripheral resistance; the elevated SHBG excludes this. TSHoma (B) fits perfectly: inappropriate TSH secretion, peripheral tissue sensitivity (elevated SHBG), and pituitary adenoma. Graves' disease (C) would show suppressed TSH. Familial dysalbuminemic hyperthyroxinemia (D) would show normal TSH and normal free T4 by equilibrium dialysis. Heterophile antibody interference (E) causes laboratory artifact without true thyroid hormone excess or elevated SHBG. The keyed answer B is uniquely defensible based on the constellation of biochemical findings and imaging. Medical accuracy is excellent; the distinction between RTH and TSHoma via SHBG is a classic teaching point. No fix needed—this is a well-constructed item testing appropriate differential diagnosis of thyrotoxicosis with non-suppressed TSH.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-009", "question": "A 48-year-old male who works as a tool grinder presents with chronic dry cough and dyspnea. Bronchoalveolar lavage (BAL) reveals multinucleated giant cells that appear to be engulfing other cells ('cannibalistic' giant cells). Which of the following exposures is most likely responsible for this finding?", "options": ["Silica", "Asbestos", "Cobalt", "Beryllium", "Coal dust"], "answer": "C", "answer_index": 2, "explanation": "The presence of 'cannibalistic' multinucleated giant cells in BAL or biopsy is pathognomonic for Hard Metal Lung Disease (Giant Cell Interstitial Pneumonia). This is caused by exposure to Cobalt, often in the form of tungsten carbide alloy used in tool grinding, diamond polishing, or saw sharpening. Beryllium causes granulomas similar to sarcoidosis, not GIP.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a tool grinder with chronic respiratory symptoms and BAL showing multinucleated giant cells with 'cannibalistic' appearance (engulfing other cells). This pathognomonic finding points to Giant Cell Interstitial Pneumonia (GIP), also known as Hard Metal Lung Disease, caused by cobalt exposure in tungsten carbide alloys used in tool grinding. Key discriminating findings: (1) occupation as tool grinder, (2) chronic respiratory symptoms, (3) specific BAL cytology showing cannibalistic giant cells. The keyed answer (C. Cobalt) correctly identifies the causative agent. Alternative assessment: A. Silica causes silicosis with birefringent particles and nodular fibrosis, not GIP. B. Asbestos causes asbestosis with ferruginous bodies, not cannibalistic giant cells. D. Beryllium causes chronic berylliosis with non-caseating granulomas resembling sarcoidosis, not GIP. E. Coal dust causes coal worker's pneumoconiosis with coal macules, not this cytologic pattern. The cannibalistic giant cell finding is pathognomonic for hard metal disease, making this a valid single-best-answer item. Medical accuracy is excellent; the association between cobalt/tungsten carbide exposure in tool grinding and GIP with characteristic cytology is well-established. No fix needed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a tool grinder with chronic respiratory symptoms and BAL showing multinucleated giant cells with 'cannibalistic' appearance (engulfing other cells). This pathognomonic finding points to Giant Cell Interstitial Pneumonia (GIP), also known as Hard Metal Lung Disease, caused by cobalt exposure in tungsten carbide alloys used in tool grinding. Key discriminating findings: (1) occupation as tool grinder, (2) chronic respiratory symptoms, (3) specific BAL cytology showing cannibalistic giant cells. The keyed answer (C. Cobalt) correctly identifies the causative agent. Alternative assessment: A. Silica causes silicosis with birefringent particles and nodular fibrosis, not GIP. B. Asbestos causes asbestosis with ferruginous bodies, not cannibalistic giant cells. D. Beryllium causes chronic berylliosis with non-caseating granulomas resembling sarcoidosis, not GIP. E. Coal dust causes coal worker's pneumoconiosis with coal macules, not this cytologic pattern. The cannibalistic giant cell finding is pathognomonic for hard metal disease, making this a valid single-best-answer item. Medical accuracy is excellent; the association between cobalt/tungsten carbide exposure in tool grinding and GIP with characteristic cytology is well-established. No fix needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-010", "question": "A 52-year-old male presents to the ED 2 hours after ingesting a massive overdose of sustained-release Verapamil. He is hypotensive (BP 60/40 mmHg) and bradycardic (HR 38 bpm). He remains hypotensive despite 3 liters of crystalloid, IV Calcium Gluconate, and IV Glucagon. Which of the following is the most appropriate next therapeutic intervention?", "options": ["High-dose Insulin Euglycemia therapy", "Transvenous Pacing", "Hemodialysis", "IV Amiodarone", "IV Lipid Emulsion (20%)"], "answer": "A", "answer_index": 0, "explanation": "High-dose Insulin Euglycemia (HIE) is the recommended therapy for severe calcium channel blocker toxicity refractory to initial measures (fluids, calcium). Insulin has a positive inotropic effect and improves myocardial glucose utilization in the stressed heart. While lipid emulsion is a salvage therapy, HIE has stronger evidence as a first-line pharmacologic support after calcium/fluids. Transvenous pacing often fails to capture or improve cardiac output in severe CCB poisoning due to global myocardial depression.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes severe sustained-release verapamil overdose with refractory shock (hypotension, bradycardia) despite standard initial measures (fluids, calcium gluconate, glucagon). Key discriminating findings: massive CCB overdose, persistent hypotension/bradycardia after first-line therapies. High-dose insulin euglycemia (HIE) therapy is the established next-step intervention for refractory CCB toxicity, supported by toxicology guidelines and consensus statements. HIE improves myocardial contractility and metabolic function. Option B (transvenous pacing) typically fails in severe CCB toxicity due to myocardial depression and inability to capture. Option C (hemodialysis) is ineffective for verapamil (high volume of distribution, protein binding). Option D (amiodarone) would worsen bradycardia and hypotension. Option E (lipid emulsion) is considered salvage therapy after HIE failure, not before. The item is logically valid with a single defensible best answer matching the key. Medical accuracy is excellent, reflecting current toxicology standards. No fix needed; the question appropriately tests knowledge of refractory CCB overdose management hierarchy.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes severe sustained-release verapamil overdose with refractory shock (hypotension, bradycardia) despite standard initial measures (fluids, calcium gluconate, glucagon). Key discriminating findings: massive CCB overdose, persistent hypotension/bradycardia after first-line therapies. High-dose insulin euglycemia (HIE) therapy is the established next-step intervention for refractory CCB toxicity, supported by toxicology guidelines and consensus statements. HIE improves myocardial contractility and metabolic function. Option B (transvenous pacing) typically fails in severe CCB toxicity due to myocardial depression and inability to capture. Option C (hemodialysis) is ineffective for verapamil (high volume of distribution, protein binding). Option D (amiodarone) would worsen bradycardia and hypotension. Option E (lipid emulsion) is considered salvage therapy after HIE failure, not before. The item is logically valid with a single defensible best answer matching the key. Medical accuracy is excellent, reflecting current toxicology standards. No fix needed; the question appropriately tests knowledge of refractory CCB overdose management hierarchy.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]